4/24/2008
Research without Worry - Apple Inc. Business Profile
1/30/2008
Bright ideas corner cash at venture capital forum
12/19/2007
Presenters At Upcoming Venture Capital Conference Announced
8/16/2007
eFlorida Life Science Innovators
4/23/2007
“Intezyne Technologies,” Greater Tampa Chamber of Commerce

Drug Delivery System Development

Intezyne Technologies is a biotechnology corporation developing synthetic polymers for targeted drug delivery systems. For more information, please contact us at info@intezyne.com, and click on the following link to learn more about Our Technology.

While the design, formulation, and administration of a drug delivery system will vary widely across the spectrum of drug types, the ultimate goal of a targeted drug delivery system is the same - deliver the ideal concentration of a therapeutic to the site of disease while minimizing side effects to healthy cells and tissue. Most modern drug delivery systems are specifically tailored to deliver a single drug type or attempt to address only a few of the difficult problems associated with targeting therapeutic delivery.

Utilizing expertise in organic and polymer chemistry, Intezyne has taken a fundamentally different, bottom-up approach to addressing the most pressing deficiencies associated with currently available drug delivery systems. Through the rational design and chemical tailoring of new polymer materials, Intezyne has developed the IVECT™ drug delivery platform (DDP) to make targeted drug delivery a reality, improving the lives of people who suffer from disease and offering enhanced product value for our potential pharmaceutical partners.
Drug Delivery System | Drug Delivery
COMPANY PROFILE | OUR TECHNOLOGY | NEWS | CONTACT US | INTEZYNE HOME
INTEZYNE technologies © 2007